Literature DB >> 9025141

The performance of southern African territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines.

P Hunter1.   

Abstract

The performance of selected oil adjuvants containing Southern African Territories (SAT) serotypes of foot and mouth disease virus was assayed by testing antibody levels elicited in cattle, sheep and goats, and by testing protection of cattle on challenge. Various oil adjuvant formulations were tested initially in cattle and guinea pigs, and compared with a standard alhydrogel and saponin-based (AS) vaccine. A commercial double oil emulsion vaccine elicited higher antibody titres and a more prolonged antibody response than the conventional AS vaccine, than a commercial single emulsion oil formulation or an incomplete Freund's adjuvant formulation. Incomplete Freund's adjuvant was selected for the formulation of a trivalent vaccine which was assayed in cattle, sheep and goats for antibody response and local reactions. The double oil emulsion elicited a high level of antibodies, which was maintained for at least six months after a single inoculation. The product was easily injectable and did not cause local or systemic reactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9025141     DOI: 10.20506/rst.15.3.954

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  3 in total

1.  Characterization of the structural-protein-coding region of SAT 2 type foot-and-mouth disease virus.

Authors:  H G van Rensburg; L H Nel
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Evaluation of Potency and Duration of Immunity Elicited by a Multivalent FMD Vaccine for Use in South Africa.

Authors:  Faith R M Peta; M M Sirdar; Peter van Bavel; P B Mutowembwa; N Visser; J Olowoyo; M Seheri; Livio Heath
Journal:  Front Vet Sci       Date:  2021-12-15

Review 3.  Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review.

Authors:  Sarah J Cox; Paul V Barnett
Journal:  Vet Res       Date:  2008-12-02       Impact factor: 3.683

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.